What was HH Biotechnology Holdings Co’s price range in the past 12 months?
HH Biotechnology Holdings Co lowest stock price was $0.07 and its highest was $0.75 in the past 12 months.
What is HH Biotechnology Holdings Co’s market cap?
HH Biotechnology Holdings Co’s market cap is $1,406.
When is HH Biotechnology Holdings Co’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is HH Biotechnology Holdings Co overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does HH Biotechnology Holdings Co pay dividends?
HH Biotechnology Holdings Co does not currently pay dividends.
What is HH Biotechnology Holdings Co’s EPS estimate?
HH Biotechnology Holdings Co’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HH Biotechnology Holdings Co have?
HH Biotechnology Holdings Co has 14,060,000 shares outstanding.
Which hedge fund is a major shareholder of HH Biotechnology Holdings Co?
Currently, no hedge funds are holding shares in HHBT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HH Biotechnology Holdings Co
HH Biotechnology Holdings Company operates within the health and green industries. Its primary activities include the cultivation and distribution of macadamia nuts, which are then utilized in a broad spectrum of products, including foodstuffs, culinary oils, wellness items, personal care products, and cosmetic formulations. The entity, originally established in 1987, was previously named Great China International Holdings, Inc. before rebranding to HH Biotechnology Holdings Company in August 2016. Its corporate headquarters are situated in Shenyang, People's Republic of China.